Business Context and Reporting Period
Company: Franklin BSP Realty Trust, Inc. (FBRT)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: FBRT is a Maryland corporation taxed as a Real Estate Investment Trust (REIT) that originates, acquires, and manages a diversified portfolio of commercial real estate debt investments. The company is externally managed by Benefit Street Partners L.L.C. (the "Advisor"), a subsidiary of Franklin Templeton. Its primary strategies include originating first and subordinate mortgage loans, investing in real estate securities (CMBS, CDOs), originating conduit loans for securitization, and managing real estate owned (REO) acquired through foreclosure.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Net Interest Income | $187.6 million | $246.9 million |
| Total Income | $210.5 million | $264.0 million |
| Net Income (GAAP) | $92.4 million | $144.5 million |
| Net Income Attributable to Common Stock | $68.9 million | $118.2 million |
| Diluted EPS | $0.82 | $1.42 |
| Provision for Credit Losses | $35.7 million | $33.7 million |
| Total Assets | $6.00 billion | $5.96 billion |
| Total Liabilities | $4.39 billion | $4.28 billion |
| Stockholders' Equity | $1.51 billion | $1.56 billion |
| Book Value Per Share | $15.09 | $15.71 |
| Net Debt-to-Equity Ratio | 2.6x | 2.3x |
| Unrestricted Cash | $184.4 million | $337.6 million |
Material Changes vs. Prior Period
- Decline in Net Income: Net income decreased by $52.1 million (36%) to $92.4 million. This was primarily driven by a $26.4 million decrease in interest income and a $32.9 million increase in interest expense.
- Interest Income Reduction: The decrease in interest income was largely due to the absence of a $20.4 million non-recurring gain from a Brooklyn hotel asset sale in 2023 and an increase in non-performing loans averaging $190.9 million in 2024.
- Increased Interest Expense: Interest expense rose due to a $429.6 million increase in the average carrying value of Collateralized Loan Obligations (CLOs) and higher deferred fee amortization, partially offset by a reduction in repurchase agreement balances.
- Credit Loss Provisions: The provision for credit losses increased slightly to $35.7 million. While the general allowance decreased by $0.3 million due to a favorable macroeconomic outlook, the specific allowance increased by $36.0 million, primarily related to two non-performing office loans in Colorado and Georgia.
- Real Estate Owned (REO) Growth: Revenue from REO increased to $22.8 million from $17.0 million, driven by rental income from additional multifamily properties acquired via foreclosure. However, the company recorded an $8.0 million loss on other real estate investments, largely due to write-offs and sales related to the Walgreens Portfolio.
- Liquidity Position: Unrestricted cash decreased significantly from $337.6 million to $184.4 million. Total liquidity sources (cash, CLO reinvestment, and financing lines) dropped from $1.52 billion to $535 million.
Guidance, Outlook, Risks, and Unusual Items
- Management Commentary: Management noted that the decrease in net income was impacted by the lack of non-recurring items present in the prior year and higher financing costs associated with CLOs. The company continues to focus on originating commercial real estate debt and managing its REO portfolio.
- Dividends: The Board declared a fourth-quarter 2024 common stock dividend of $0.355 per share (annualized $1.42). Preferred dividends were also declared for Series E and Series H stock.
- Share Repurchases: The company has a $65 million share repurchase program extended through December 31, 2025. As of December 31, 2024, $31.1 million remained available. No repurchases were made in Q4 2024.
- Key Risks:
- Financing Strategy: Significant indebtedness and reliance on short-term borrowings (repos) and securitization markets (CLOs). Rising interest rates increase interest expense faster than asset yields in some cases.
- Credit Risk: Exposure to commercial real estate defaults, particularly in office and hospitality sectors. The company has three non-performing loans totaling $133.2 million as of year-end.
- Liquidity: Short-term borrowings require collateral maintenance; declines in asset values could trigger margin calls.
- REIT Qualification: Failure to meet REIT requirements would subject the company to corporate income tax.
- Unusual Items:
- Walgreens Portfolio: Continued losses and write-downs associated with the 24-property retail portfolio acquired due to sponsor fraud. A $10.7 million loss was recorded in 2024.
- Non-Performing Loans: Specific allowances were recorded for office properties in Colorado and Georgia and a multifamily property in Texas.
Important Facts for Investor Verification
- Non-Performing Loan Concentration: Verify the status and recovery prospects of the three non-performing loans ($133.2 million amortized cost), specifically the office loans in Colorado and Georgia which drove the specific credit loss provision.
- Walgreens Portfolio Resolution: Monitor the remaining four retail properties from the Walgreens Portfolio held for sale and the ongoing litigation against the sponsor for potential recoveries.
- Liquidity and Refinancing: Assess the company's ability to refinance short-term repurchase agreements and manage CLO maturities given the reduction in unrestricted cash and available financing lines.
- Interest Rate Sensitivity: Evaluate the impact of sustained high interest rates on the spread between asset yields and financing costs, particularly given the increase in CLO leverage.
- REO Performance: Review the cash flow generation and exit strategy for the growing Real Estate Owned portfolio, which now includes 12 properties held for sale and 3 held for investment.